Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic liver diseases

Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 1

Abstract

Authors and Affiliations

Priya Handa, Kris V. Kowdley

Keywords

Related Articles

Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection

[b]Background[/b]. Hepatitis C is a leading cause of mortality among HIV-infected individuals. Therefore, eradication of HCV in this population is a priority. There are scarce data regarding retreatment efficacy of HIV/...

Conversion to mycophenolate mofetil monotherapy in liver recipients: Calcineurin inhibitor levels are key

The use of calcineurin inhibitors (CNI) after liver transplantation is associated with post-transplant nephrotoxicity. Conversion to mycophenolate mofetil (MMF) monotherapy improves renal function, but is related to gra...

Older age is associated with increased early mortality after transjugular intrahepatic portosystemic shunt

Introduction & Aim. The role of age as a predictor of mortality after transjugular intra hepatic portosystemic shunt (TIPS) is controversial. Age has been found to be an important predictor of post-TIPS morta...

The efficacy and safety of nucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure: a meta-analysis

[b]Background and purpose[/b]. The application of nucleos(t)ide analogues in hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF) has not yet been widely accepted. Therefore, we conducted a metaanalysis...

Capsulorrhaphy in the management of liver hydatid cyst

Introduction. Hydatid disease is a major health problem in some parts of the world. There are several nonoperative and operative ways to treat hydatic disease. The aim of this retrospective study is to assess the rate of...

Download PDF file
  • EP ID EP78370
  • DOI -
  • Views 126
  • Downloads 0

How To Cite

Priya Handa, Kris V. Kowdley (2014). Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic liver diseases. Annals of Hepatology, 13(1), 152-154. https://europub.co.uk/articles/-A-78370